Literature DB >> 11390584

Thymic lesions in cats infected with a pathogenic molecular clone or an ORF-A/2-deficient molecular clone of feline immunodeficiency virus.

R M Norway1, P C Crawford, C M Johnson, A Mergia.   

Abstract

Previous studies using feline immunodeficiency virus (FIV) molecular clones lacking the putative transactivator gene (ORF-A/2) failed to address the issue of thymus pathogenesis or investigate the levels of viral replication in separate lymphoid compartments (Y. Inoshima, et al., J. Virol. 70:8518-8526, 1996; E. E. Sparger, et al., Virology 205:546-553, 1994). Using a highly pathogenic molecular clone of FIV, JSY3, and an ORF-A/2-deficient mutant, JSY3DeltaORF-A/2, we compared viral replication and the extent of thymic dysfunction as measured by the formation of lymphoid follicles and alteration of the thymocyte subsets. Viral replication was reduced in JSY3DeltaORF-A/2-infected cats as measured by lymphocyte coculture, immunohistochemistry, and quantitative PCR. Cell-associated viral load measured by lymphocyte coculture varied in a tissue-dependent manner with replication highest in lymphocytes isolated from the thymus, lower in those from the peripheral blood, and lowest in those from lymph node. Thymic proviral load and the number of viral p24 Gag-positive cells within the thymus detected by immunohistochemistry were also reduced. In addition, the onset of a reduced peripheral blood CD4/CD8 ratio was delayed in JSY3DeltaORF-A/2-infected cats. The formation and extent of thymic lymphoid follicular hyperplasia were similar in JSY3 and JSY3DeltaORF-A/2-infected cats as measured by anticytokeratin immunohistochemistry and flow cytometry for percent pan T-negative, immunoglobulin G-positive cells within the thymus. In contrast, comparison of thymocyte subpopulations demonstrated a reduced expansion of single-positive CD4(-) CD8(+) thymocytes in JSY3DeltaORF-A/2-infected cats. Level of viral replication, therefore, may not correlate with the formation of thymic lymphoid follicles but may correlate with the expansion of the single-positive CD4(-) CD8(+) thymocyte subpopulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390584      PMCID: PMC114298          DOI: 10.1128/JVI.75.13.5833-5841.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Dose response studies of acute feline immunodeficiency virus PPR strain infection in cats.

Authors:  R M Hokanson; J TerWee; I S Choi; J Coates; H Dean; D N Reddy; A M Wolf; E W Collisson
Journal:  Vet Microbiol       Date:  2000-10-20       Impact factor: 3.293

2.  Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.

Authors:  D Camerini; H P Su; G Gamez-Torre; M L Johnson; J A Zack; I S Chen
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.

Authors:  R M Scoggins; J R Taylor; J Patrie; A B van't Wout; H Schuitemaker; D Camerini
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

5.  CD8+ thymic lymphocytes express reduced levels of CD8beta and increased interferon gamma in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus.

Authors:  M S Orandle; P C Crawford; J K Levy; R Udoji; G P Papadi; T Ciccarone; A Mergia; C M Johnson
Journal:  AIDS Res Hum Retroviruses       Date:  2000-10-10       Impact factor: 2.205

6.  Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus.

Authors:  K A Hayes; A J Phipps; S Francke; L E Mathes
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

7.  T cells overexpressing interferon-gamma and interleukin-10 are found in both the thymus and secondary lymphoid tissues of feline immunodeficiency virus-infected cats.

Authors:  Y Liang; L C Hudson; J K Levy; J W Ritchey; W A Tompkins; M B Tompkins
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

8.  Interleukin-2 suppression in cats naturally infected with feline leukemia virus.

Authors:  M B Tompkins; G K Ogilvie; A M Gast; R Franklin; R Weigel; W A Tompkins
Journal:  J Biol Response Mod       Date:  1989-02

9.  Investigation of recombinant human insulin-like growth factor type I in thymus regeneration in the acute stage of experimental FIV infection in juvenile cats.

Authors:  J C Woo; G A Dean; A Lavoy; R Clark; P F Moore
Journal:  AIDS Res Hum Retroviruses       Date:  1999-10-10       Impact factor: 2.205

10.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

View more
  3 in total

Review 1.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

2.  Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Authors:  Malou C Gemeniano; Earl T Sawai; Christian M Leutenegger; Ellen E Sparger
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Viral gene expression and provirus load of Orf-A defective FIV in lymphoid tissues and lymphocyte subpopulations of neonatal cats during acute and chronic infections.

Authors:  Janelle M Novak; P Cynthia Crawford; Holly M Kolenda-Roberts; Calvin M Johnson; Ayalew Mergia
Journal:  Virus Res       Date:  2007-07-17       Impact factor: 3.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.